Immunology Clinical Trials List India - Immunology Clinical Research & Study Center

Swap Transplant

If you are looking for any ongoing clinical trials, try our "Clinical Research Search "

List of "Immunology" clinical trials

CTRI/2009/091/000665 A Clinical study of Pentavalent vaccine	CTRI/2009/091/000375 A clinical study on Pentavalent vaccine	CTRI/2008/091/000100 A clinical study to assess protection against Rubella and also to assess the safety and immunogenicity of rubella vaccine in teenaged girls in Maharashtra	CTRI/2010/091/000028 A clinical study to Evaluate The Safety, Tolerability And Immunogenicity Of Three Formulations (15µg Without Adjuvant, 7.5µg With Adjuvant And 3.75µg With Adjuvant) Of Monovalent H1N1 Influenza A (2009) Virus Vaccine In Healthy Adults.
CTRI/2010/091/000008 A clinical trial of H1N1 vaccine (Live attenuated) in Adults.	CTRI/2010/091/000082 A clinical trial of SIIL`s H1N1 vaccine (Inactivated) in Adults.	CTRI/2009/091/000615 A clinical trial to assess and compare the safety of Pentavac Vaccine (DTP-HB+Hib) of SIIL with Tritanrix-HB-HIB of GSK in Indian infants.	CTRI/2009/091/000394 A clinical trial to assess immunogenicity and safety of combination vaccine (Diphtheria-Tetanus-whole cell Pertussis-Hepatitis B) as compared with Active Comparator (Combined DTPw-HB Vaccine) and to demonstrate the equivalence of three different lots of LBVW0101, in terms of immunogenicity, in healthy infants at six, ten and fourteen weeks of age.
CTRI/2009/091/000465 A clinical trial to assess the safety and rabies antibody levels in blood following a new Human Monoclonal Antibody to Rabies (SII RMab) in comparison with Human Rabies Immune Globulin, when given together with Rabies Vaccine (RABIVAX®) in healthy adults.	CTRI/2009/091/000843 A clinical trial to assess to assess immunogenicity and safety of LBVF0101(combined vaccine which is reconstituted from LBVW0101 (Diphtheria-Tetanus-whole cell Pertussis-Hepatitis B) and LBVH0101 (Haemophilus influenzae type b tetanus toxoid conjugate vaccine) just before intramuscular injection} compared with combined vaccine which is reconstituted from Tritanrix HB®(Diphtheria-Tetanus-whole cell Pertussis-Hepatitis B) and Hiberix® (Haemophilus influenzae type b tetanus toxoid conjugate vaccine) just before intramuscular injection in healthy infants at six, ten and fourteen weeks of age.	CTRI/2011/091/000108 A clinical trial to evaluate the Safety and Immunogenicity of BE`s Inactivated Japanese Encephalitis Vaccine	CTRI/2010/091/001086 A clinical trial to evaluate the safety and reactogenicity of BE`s Inactivated Japanese Encephalitis Vaccine.
CTRI/2010/091/000260 A Clinical Trial to evaluate the safety of a Tetravalent Rotavirus Vaccine in healthy adult male volunteers.	CTRI/2009/091/000137 A clinical trial to generate scientific evidence on the efficacy of a two-dose HPV vaccination regimen as compared to the current standard three-dose regimen	CTRI/2010/091/000649 A clinical trial to observe the safety and reactogenicity of pentavalent vaccine, after reconstitution of freeze dried HIB Vaccine with DTwP-rHepB liquid vaccine, before administration.	CTRI/2010/091/002807 A clinical trial to see whether an alternate vaccination schedule of the killed oral cholera vaccine is as immunogenic as the standard vaccine schedule
CTRI/2010/091/000509 A clinical trial to study immunogenicity and safety of Purified Chick Embryo Cell Culture Rabies Vaccine administered intradermally.	CTRI/2010/091/000055 A clinical trial to study immunogenicity and safety of Purified Chick Embryo Cell Culture Rabies Vaccine in post-exposure animal bite cases.	CTRI/2009/091/000298 A clinical trial to study prevention of HPV in HIV-Positive women in India	CTRI/2010/091/000518 A clinical trial to study the effect of two drugs, Brivudin Tablets and Famciclovir Tablets in patients with Acute herpes zoster in immunocompetent adult.
CTRI/2010/091/000006 A clinical trial to study the effects of Inactivated influenza vaccine (H1N1)in healthy adult male human subjects.	CTRI/2010/091/000107 A clinical trial to study the effects of ZYH1 in patients with high triglyceride levels in HIV associated lipodystrophy.	CTRI/2010/091/000182 A clinical trial to study the immunogenicity and safety of Inactivated Influenza Vaccine in healthy adult volunteers.	CTRI/2010/091/003031 A clinical trial to study the optimal use of conjugate typhoid vaccine- Single dose vs two doses.
CTRI/2009/091/000368 A clinical trial to study the safety and the consistency in terms of protection between three production lots of the PsA-TT conjugate vaccine produced at large scale in the 5 to 10 years of age.	CTRI/2008/091/000198 A community based cluster randomized trial evaluating efficacy of an HIV stigma reduction intervention where people living with HIV and their friends (PLWHAF) would work hand in hand with local performing artists	CTRI/2010/091/000214 A Comparative Phase III Clinical Study of Bharat Biotech International Limited Rabies Vaccine INDIRAB reconstituted with 1mL diluent Vs Reference Vaccine, administered Intramuscularly in healthy volunteers as Pre-Exposure treatment.	CTRI/2010/091/000301 A first-in-man clinical trial to evaluate the safety and immunogenicity of different doses of a malaria Vaccine (JAIVAC-1) in healthy Indian Male Subjects between 18 to 45 years of age.
CTRI/2010/091/003049 A multi-centre, single intravenous dose, exploratory dose-finding, open label trial on the safety and efficacy of Sym001 in the treatment of Immune Thrombocytopenic Purpura (ITP) in RhD positive, non-splenectomized adult subjects.	CTRI/2010/091/000093 A multicentric clinical trial of SIIL`s H1N1 vaccine (Inactivated) in Adults.	CTRI/2010/091/000092 A multicentric clinical trial of SIIL`s H1N1 vaccine (Live) in Adults.	CTRI/2010/091/000032 A phase II/III clinical study to evaluate the immunogenicity and safety of three formulations of monovalent H1N1 influenza A (2009) virus vaccine in healthy adults.
CTRI/2010/091/000031 A Phase II/III clinical Study to Evaluate the Immunogenicity and Safety of Three Formulations of Monovalent H1N1 Influenza A (2009) Virus Vaccine, Manufactured by Panacea Biotec Ltd., in Healthy Pediatric Population 3-9 years of Age.	CTRI/2010/091/000029 A Phase II/III clinical Study to Evaluate the Immunogenicity and Safety of Three Formulations of Monovalent H1N1 Influenza A (2009) Virus Vaccine, Manufactured by Panacea Biotec Ltd., in Healthy Pediatric Population 6 - 35 Months of Age.	CTRI/2010/091/000661 A Phase II/III Clinical Study to Evaluate the Safety and Efficacy of HN-VAC (Influenza A/H1N1 Adjuvant vaccine) Produced by BBIL in healthy volunteers.	CTRI/2010/091/000102 A Phase III Clinical Trial to evaluate the protective efficacy of three doses of Oral Rotavirus Vaccine (ORV) 116E.
CTRI/2009/091/000456 A phase III clinical trial to study the safety and immunogenicity of BE`s combined pentavalent DTwP-rHepB-HIB liquid vaccine administered to 6-8 week old healthy Infants of either gender in comparison with a marketed vaccine.	CTRI/2009/091/000539 A phase IV clinical trial to study the safety and immunogenicity of a single booster dose of BE`s Tetanus Toxoid vaccine BETT administered to 18-50 year old healthy Indian adults of either gender.	CTRI/2010/091/000152 A Phase-I Clinical Trial to study the Safety and efficacy of Bharat Biotech International Limited Influenza A H1N1 pandemic 2009 Vaccine (Inactivated) in healthy volunteers.	CTRI/2010/091/000204 A Phase-III clinical trial to study the safety and immunogenicity of Bharat Biotech International Limited bivalent Oral Poliomyelitis Vaccine Type-1&3 vs. WHO pre-qualified trivalent polio vaccine in healthy neonates.
CTRI/2010/091/000213 A Phase-III Clinical Trial to study the Safety and Immunogenicity of Bharat Biotech monovalent Oral Poliomyelitis Vaccine Type 3 vs. WHO prequalified trivalent Oral Polio Vaccine in healthy neonates.	CTRI/2010/091/000203 A Phase-III clinical trial to study the safety and immunogenicity of Bharat Biotech monovalent Oral Poliomyelitis Vaccine Type-1 vs. WHO prequalified trivalent Oral Polio Vaccine in healthy neonates.	CTRI/2009/091/000669 A Post Marketing Surveillance study of BCG vaccine in Indian population	CTRI/2010/091/003064 A Randomized, Double-Blind, Placebo Controlled Study to Assess Safety and Tolerability of RotaVac Vaccine (Live Attenuated Bovine-Human (UK) Reassortant Pentavalent Rotavirus Vaccine)
CTRI/2009/091/000821 A Randomized, Double-Blind, Placebo Controlled Study To Assess the Safety And Tolerability Of RotaVac Vaccine (Live Attenuated Bovine-Human (UK) Reassortant Pentavalent Rotavirus Vaccine)	CTRI/2009/091/000644 A Study in couples in which one partner is infected with HIV and the other partner is not infected. The primary goal is to find out whether treating HIV infected partner with Anti-HIV drugs can prevent them from transmitting the virus to their partner through sex	CTRI/2010/091/000157 A Study of Meningococcal Vaccine, Menactra® in Healthy Subjects in India.	CTRI/2009/091/000767 A Study of V503 (Multivalent HPV Vaccine) in Preadolescents and Adolescents. This study will evaluate the immunogenicity and tolerability of V503 in preadolescent and adolescent subjects between 9 and 15 years old and demonstrate the consistency of the manufactured vaccine through assessment of 3 different final manufacturing process lots of V503.
CTRI/2010/091/001234 ACTG 5253: Observational Study of Specificity of Mycobacterium Tuberculosis Screening and Diagnostics in HIV-Infected Individuals	CTRI/2010/091/001261 An Open Labeled, Noncomparative, Phase I Study to Evaluate the Safety and Tolerability of a Fully Liquid Pentavalent DTwP-Hib-IPV Vaccine (EasyfourpolTM) of Panacea Biotec Ltd. Administered in Healthy Children 15- 18 Months of age.	CTRI/2009/091/000887 Clinical Study to compare and evaluate the immunogenicity and reactogenicity of Inactivated Polio Vaccine of Panacea Biotec Ltd. with Imovax Polio of Sanofi Pasteur India Pvt Ltd. in Healthy infants.	CTRI/2008/091/000105 Clinical trial on Hepatitis C
CTRI/2009/091/000860 Clinical trial to assess the safety and the efficacy of a new intravenous immune globulin (IGIV3I Grifols10%) in patients with idiopathic (immune) thrombocytopenic purpura.	CTRI/2010/091/003002 Community based prevention of rotavirus gastroenteritis by a functional food supplement	CTRI/2010/091/000591 COMPARATIVE EVALUATION OF IMMUNOGENICITY AND REACTOGENICITY OF BIVALENT ORAL POLIOVIRUS VACCINE VERSUS PRE QUALIFIED BIVALENT ORAL POLIOVIRUS VACCINE : A RANDOMIZED DOUBLE-BLIND TRIAL.	CTRI/2009/091/000750 Comparison of GSK measles-mumps-rubella-varicella (MMRV) vaccine versus PriorixTM
CTRI/2010/091/000220 Efficacy of neonatal vitamin A supplementation in improving child survival in Haryana, India: generation of evidence necessary for informing global policy.	CTRI/2009/091/000802 ELT209: A Phase Two, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of the Travelers Diarrhea Vaccine System in Travelers to Asia.	CTRI/2009/091/000051 IAVI P001: A Phase I trial where the volunteers are randomly allocated in a blinded manner to 2 groups to receive either TBC-M4, a multigenic MVA HIV Vaccine or ADVAX, a multigenic DNA HIV Vaccine followed by TBC-M4, a multigenic MVA HIV Vaccine or placebo to evaluate the Safety and Immunogenicity of TBC-M4 or ADVAX followed by TBC-M4.	CTRI/2009/091/000652 Protocol No. ACTG 5175 : Protocol :EVALUATION OF THE EFFICACY OF ANTIRETROVIRAL THERAPY FOR INITIAL TREATMENT OF HIV-1 INFECTED INDIVIDUALS :-ONCE-DAILY PROTEASE INHIBITOR- AND ONCE-DAILY NON-NUCLEOSIDE REVERSE TRAN ASE INHIBITOR-CONTAINING THERAPY COMBINATIONS
CTRI/2009/091/000570 Reactogenicity and safety of GlaxoSmithKline (GSK) Biologicals Rotarix (human rotavirus vaccine) in Indian infants	CTRI/2011/091/000099 Sero-surveillance to assess rubella susceptibility including assessment of immunogenicity and safety of Rubella vaccine in females aged 18-24 years.	CTRI/2009/091/000374 Study of antiviral activity of DRV in combination with low dose ritonavir in the treatment experienced HIV-1 infected childerns from 3 years to < 6 years of age.	CTRI/2010/091/000683 TMC114-TiDP29-C232 Continued access to darunavir/ritonavir (DRV/rtv) in HIV-1 infected children and adolescents aged 3 years and above
CTRI/2008/091/000148 To Evaluate the Efficacy, Safety, Tolerability, and to identify the Best Dose of Atacicept for the treatment of patients having recently experienced a flare of Systemic Lupus Erythematosus (SLE)	CTRI/2010/091/001125 To evaluate the Safety and Immunogenicity of the Tetrabhay DTwP-H (Diphtheria, Tetanus, whole cell Bordetella Pertussis and Hepatitis B) vaccine in comparison with commercially available ShantetraTM vaccine in healthy children	CTRI/2010/091/000426 Vaccination order and Pain response in Newborns.	CTRI/2009/091/000673 WHO/MAP/IND/02 Pivotal study to evaluate the immunogenicity and safety of a measles vaccine given by aerosolized inhalation: randomized controlled trial.